Office of Biotechnology Activities    National Institutes of Health - Office of Science Policy   Institutional Biosafety Committees   Institutional Biosafety Committees (IBCs) are the cornerstone of institutional oversight of recombinant DNA research. The following information and resources are provided to help IBCs perform this critical role, as well as to inform others about the roles and responsibilities of these important committees.     Key Definitions and Acronyms     Frequently Asked Questions     Guidance Documents     Investigator Responsibilities Under the NIH Guidelines for Research Involving Recombinant DNA Molecules (June 22, 2009)     Tool for the Self-Assessment of the Institutional Biosafety Committee and Program of Oversight of Recombinant DNA Research (June 22, 2009)     Memorandum describing how to use the self-assessment tool.     Self-assessment tool      -  Fillable PDF (requires Adobe Acrobat 9.0 and higher to electronically save data)      -  Excel spreadsheet (with electronically fillable fields)     Major Actions Requiring NIH Director Approval (March 21, 2008)     Additional Guidance on the Content of Minutes of Institutional Biosafety Committee Meetings (February 23, 2007)     Institutional Compliance Reminder (December 6, 2004)     Guidance on Minutes of Institutional Biosafety Committee Meetings (May 14, 2004)     Workshops, Safety Symposia and Policy Conferences     Links of Interest to IBCs     Subscribe to OBA News     If you have questions about OBA's activities, interpretations of the NIH Guidelines, upcoming meetings, or related matters, do not hesitate to contact OBA staff by email at oba@od.nih.gov, or by phone at 301-496-9838.

6705 Rockledge Drive, Suite 750, MSC 7985 Bethesda, MD 20892-7985 (For all non-USPS mail, please use ZIP code 20817) Phone: 301-496-9838, Fax: 301-496-9839 E-mail OBA at oba@od.nih.gov

RDNA200